Modeling the immune rheostat of macrophages in the lung in response to infection

In the lung, alternatively activated macrophages (AAM) form the first line of defense against microbial infection. Due to the highly regulated nature of AAM, the lung can be considered as an immunosuppressive organ for respiratory pathogens. However, as infection progresses in the lung, another population of macrophages, known as classically activated macrophages (CAM) enters; these cells are typically activated by IFN-γ. CAM are far more effective than AAM in clearing the microbial load, producing proinflammatory cytokines and antimicrobial defense mechanisms necessary to mount an adequate immune response. Here, we are concerned with determining the first time when the population of CAM becomes more dominant than the population of AAM. This proposed “switching time” is explored in the context of Mycobacterium tuberculosis (MTb) infection. We have developed a mathematical model that describes the interactions among cells, bacteria, and cytokines involved in the activation of both AAM and CAM. The model, based on a system of differential equations, represents a useful tool to analyze strategies for reducing the switching time, and to generate hypotheses for experimental testing.

[1]  D. Bowden The alveolar macrophage. , 1984, Environmental health perspectives.

[2]  R. Crystal,et al.  Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. , 1986, Journal of applied physiology.

[3]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[4]  S Gordon,et al.  Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation , 1992, The Journal of experimental medicine.

[5]  P. Holt,et al.  Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages , 1993, The Journal of experimental medicine.

[6]  J. Flynn,et al.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.

[7]  P. Barnes,et al.  Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. , 1993, The American review of respiratory disease.

[8]  J. Ellner,et al.  Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. , 1994, Journal of immunology.

[9]  P. Norman,et al.  Immunobiology: The immune system in health and disease , 1995 .

[10]  D. Voelker,et al.  Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. , 1995, Journal of immunology.

[11]  C. Lowenstein,et al.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.

[12]  G. Trinchieri,et al.  Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. , 1995, Journal of immunology.

[13]  P. Holt,et al.  Brief Definitive Report Dendritic Cells Are Recruited into the Airway Epithelium during the Inflammatory Response to a Broad Spectrum of Stimuli , 2022 .

[14]  B. Buddle,et al.  Sequential activation of alveolar macrophages by IFN‐γ and LPS is required for enhanced growth inhibition of virulent Mycobacterium bovis but not M. bovis BCG , 1997, Immunology and cell biology.

[15]  S. Goerdt,et al.  Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro , 1997, Immunology.

[16]  P. Kvale,et al.  Incidence of Tuberculosis in the United States among HIV-Infected Persons , 1997, Annals of Internal Medicine.

[17]  I. Orme,et al.  Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[18]  J. Keane,et al.  Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis , 1997, Infection and immunity.

[19]  W. Rom,et al.  Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol. , 1997, Lancet.

[20]  M. Burdick,et al.  Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis , 1997, Infection and immunity.

[21]  W. Rom,et al.  Treatment of multidrug-resistant pulmonary tuberculosis with interferon-γ via aerosol , 1997, The Lancet.

[22]  H. Macdonald,et al.  Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. , 1998, Journal of immunology.

[23]  C. Caux,et al.  Selective Recruitment of Immature and Mature Dendritic Cells by Distinct Chemokines Expressed in Different Anatomic Sites , 1998, The Journal of experimental medicine.

[24]  D. Havlir,et al.  Tuberculosis in patients with human immunodeficiency virus infection. , 1999, The New England journal of medicine.

[25]  P. Holt Antigen presentation in the lung. , 2000, American journal of respiratory and critical care medicine.

[26]  M. Lohmann‐Matthes,et al.  Local activation of nonspecific defense against a respiratory model infection by application of interferon-gamma: comparison between rat alveolar and interstitial lung macrophages. , 2000, American journal of respiratory cell and molecular biology.

[27]  S. Sharma,et al.  Enhanced Protection Against Fatal Mycobacterial Infection in SCID Beige Mice by Reshaping Innate Immunity with IFN-γ Transgene1 , 2001, The Journal of Immunology.

[28]  S. Kaufmann,et al.  How can immunology contribute to the control of tuberculosis? , 2001, Nature Reviews Immunology.

[29]  Denise Kirschner,et al.  A Model to Predict Cell-Mediated Immune Regulatory Mechanisms During Human Infection with Mycobacterium tuberculosis1 , 2001, The Journal of Immunology.

[30]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[31]  Ilkka Julkunen,et al.  Infection of Human Macrophages and Dendritic Cells with Mycobacterium tuberculosis Induces a Differential Cytokine Gene Expression That Modulates T Cell Response1 , 2001, The Journal of Immunology.

[32]  Giampiero Girolomoni,et al.  Regulatory Activity of Autocrine IL-10 on Dendritic Cell Functions1 , 2001, The Journal of Immunology.

[33]  JoAnne L. Flynn,et al.  Effects of Tumor Necrosis Factor Alpha on Host Immune Response in Chronic Persistent Tuberculosis: Possible Role for Limiting Pathology , 2001, Infection and Immunity.

[34]  D. Voelker,et al.  Pulmonary Surfactant Protein A Up-Regulates Activity of the Mannose Receptor, a Pattern Recognition Receptor Expressed on Human Macrophages1 , 2002, The Journal of Immunology.

[35]  M. Röllinghoff,et al.  Induction of TNF in Human Alveolar Macrophages As a Potential Evasion Mechanism of Virulent Mycobacterium tuberculosis1 , 2002, The Journal of Immunology.

[36]  Andrew G. D. Bean,et al.  TNF Regulates Chemokine Induction Essential for Cell Recruitment, Granuloma Formation, and Clearance of Mycobacterial Infection1 , 2002, The Journal of Immunology.

[37]  C. Demangel,et al.  Autocrine IL‐10 impairs dendritic cell (DC)‐derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL‐12 production , 2002, European journal of immunology.

[38]  S. Hickman,et al.  Mycobacterium tuberculosis Induces Differential Cytokine Production from Dendritic Cells and Macrophages with Divergent Effects on Naive T Cell Polarization1 , 2002, The Journal of Immunology.

[39]  J. Ernst,et al.  Mechanisms of cell recruitment in the immune response to Mycobacterium tuberculosis. , 2003, Microbes and infection.

[40]  D. Mosser,et al.  The many faces of macrophage activation , 2003, Journal of leukocyte biology.

[41]  B. Ryffel,et al.  Reactivation of Latent Tuberculosis Infection in TNF-Deficient Mice 1 , 2003, The Journal of Immunology.

[42]  S. Gordon Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[43]  D. Kirschner,et al.  The human immune response to Mycobacterium tuberculosis in lung and lymph node. , 2004, Journal of theoretical biology.

[44]  M. Miyazaki,et al.  CCL17 and IL-10 as Effectors That Enable Alternatively Activated Macrophages to Inhibit the Generation of Classically Activated Macrophages1 , 2004, The Journal of Immunology.

[45]  Matthijs Kramer,et al.  Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Stewart T. Cole,et al.  Tuberculosis and the tubercle bacillus. , 2005 .

[47]  A. Ivanov,et al.  Immune-based therapy using gamma interferon ingaron in the treatment of HIV/AIDS patients with active pulmonary tuberculosis (PTB) not previously highly active antiretroviral therapy (HAART) , 2006, Retrovirology.

[48]  D. Kirschner,et al.  Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection. , 2006, The Journal of Immunology.

[49]  Xia Zhang,et al.  Biochemical and functional characterization of three activated macrophage populations , 2006, Journal of leukocyte biology.

[50]  H. Mollenkopf,et al.  Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis , 2006, European journal of immunology.

[51]  S. Swain,et al.  Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection , 2006, The Journal of experimental medicine.

[52]  D. Kirschner,et al.  Contribution of CD8+ T Cells to Control of Mycobacterium tuberculosis Infection1 , 2006, The Journal of Immunology.

[53]  R. Reljic IFN-gamma therapy of tuberculosis and related infections. , 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[54]  M. Wewers,et al.  Lung infections and innate host defense. , 2007, Drug discovery today. Disease mechanisms.

[55]  Alberto Mantovani,et al.  Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.

[56]  D. Kirschner,et al.  A methodology for performing global uncertainty and sensitivity analysis in systems biology. , 2008, Journal of theoretical biology.

[57]  M. Davenport,et al.  Infectious diseases: Too little, too late for tuberculosis , 2008, Immunology and cell biology.

[58]  A. Friedman,et al.  A model on the influence of age on immunity to infection with Mycobacterium tuberculosis , 2008, Experimental Gerontology.